DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Lopes RD, Alexander JH, Al-Khatib SM et al.
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Am Heart J 2010;
159: 331-339
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.